The impact of achieving a sustained virological response with direct-acting antivirals on serum autotaxin levels in chronic hepatitis C patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2090-6226
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The impact of achieving a sustained virological response with direct-acting antivirals on serum autotaxin levels in chronic hepatitis C patients ; volume:10 ; number:1 ; day:9 ; month:11 ; year:2020 ; pages:1-7 ; date:12.2020
Egyptian liver journal ; 10, Heft 1 (9.11.2020), 1-7, 12.2020
- Urheber
-
Saleh, Shereen Abou Bakr
Abdelwahab, Khaled Mohamed
Mady, Asmaa Mady
Mohamed, Ghada Abdelrahman
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s43066-020-00060-w
- URN
-
urn:nbn:de:101:1-2020122021394922666920
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Saleh, Shereen Abou Bakr
- Abdelwahab, Khaled Mohamed
- Mady, Asmaa Mady
- Mohamed, Ghada Abdelrahman
- SpringerLink (Online service)
Ähnliche Objekte (12)
Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
Effect of achieving sustained virological response with direct-acting antiviral agents on glycemic control in diabetic patients with chronic hepatitis C infection
Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals
Long-Term Follow-Up of Advanced Liver Disease after Sustained Virological Response to Treatment of Hepatitis C with Direct-Acting Antivirals: Outcomes from a Real-World Portuguese Cohort
Direct-acting antivirals and visceral leishmaniasis: a case report
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals
Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
Effect of achieving sustained virological response with direct-acting antiviral agents on glycemic control in diabetic patients with chronic hepatitis C infection
Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals
Long-Term Follow-Up of Advanced Liver Disease after Sustained Virological Response to Treatment of Hepatitis C with Direct-Acting Antivirals: Outcomes from a Real-World Portuguese Cohort
Direct-acting antivirals and visceral leishmaniasis: a case report
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals
Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
Effect of achieving sustained virological response with direct-acting antiviral agents on glycemic control in diabetic patients with chronic hepatitis C infection
Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals
Long-Term Follow-Up of Advanced Liver Disease after Sustained Virological Response to Treatment of Hepatitis C with Direct-Acting Antivirals: Outcomes from a Real-World Portuguese Cohort
Direct-acting antivirals and visceral leishmaniasis: a case report
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients